MAPVIZO
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

MAPVIZO Trademark

Serial Number: 90852930

MAPVIZO is a trademark filed by Apellis Pharmaceuticals, Inc. on July 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Apellis Pharmaceuticals, Inc. (23 trademarks)

Attn: Legal Department
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

July 28, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 11, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 11, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2025 CNRT
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 21, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 22, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 24, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 26, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 24, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 24, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 26, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 26, 2022 GNSL
SUSPENSION LETTER WRITTEN
Apr 26, 2022 CNSL
ASSIGNED TO EXAMINER
Apr 25, 2022 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Apr 8, 2022 LOPT
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2021 NWOS
NEW APPLICATION ENTERED
Jul 31, 2021 NWAP